(Q37900307)

25 August 2017

1 reference

title

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes (English)

1 reference

25 August 2017

0 references

Ann Mosegaard Bak

1

1 reference

25 August 2017

Lærke Egefjord

2

1 reference

25 August 2017

Michael Gejl

3

1 reference

25 August 2017

Charlotte Steffensen

4

1 reference

25 August 2017

Chalotte Willemann Stecher

5

1 reference

25 August 2017

Kamille Smidt

6

1 reference

25 August 2017

Birgitte Brock

7

1 reference

25 August 2017

Jørgen Rungby

8

1 reference

25 August 2017

language of work or name

English

0 references

publication date

12 July 2011

1 reference

Expert Opinion on Therapeutic Targets

25 August 2017

published in

1 reference

25 August 2017

volume

15

1 reference

25 August 2017

issue

10

1 reference

25 August 2017

page(s)

1153-1162

1 reference

Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Aggregation of vascular risk factors and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Hyperinsulinemia and risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Increased risk of type 2 diabetes in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

The Role of GLP-1 in Neuronal Activity and Neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Insulin and the insulin receptor in experimental models of learning and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Intracerebroventricular insulin enhances memory in a passive-avoidance task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Insulin increases CSF Abeta42 levels in normal older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Molecular connexions between dementia and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Peripheral hyperinsulinemia promotes tau phosphorylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Common pathological processes in Alzheimer disease and type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Biological actions and therapeutic potential of the glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

GLP-1 and extra-islet effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

The source of cerebral insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Selective release of glutamine and glutamic acid produced by perfusion of GLP-1 (7-36) amide in the basal ganglia of the conscious rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Review: history of the amyloid fibril

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Islet amyloid and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

THE RELATION OE DIABETES MELLITUS TO LESIONS OF THE PANCREAS. HYALINE DEGENERATION OF THE ISLANDS OE LANGERHANS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

beta-cell failure in diabetes and preservation by clinical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

The many faces of amyloid beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

beta-Amyloid protein-induced Alzheimer's disease animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Endogenous GLP-1 modulates hippocampal activity in beta-amyloid protein-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Endogenous GLP-1 is involved in beta-amyloid protein-induced memory impairment and hippocampal neuronal death in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Neurotrophic property of geniposide for inducing the neuronal differentiation of PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

A new Alzheimer's disease interventive strategy: GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Neuroprotective properties of GLP-1: theoretical and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Neurotransmitters and CNS disease. Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

Therapeutic options in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.600691

10.1517/14728222.2011.600691

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zcwkeqlhpvci7fhzrl3jr5bjzq

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_zcwkeqlhpvci7fhzrl3jr5bjzq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zcwkeqlhpvci7fhzrl3jr5bjzq

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/zcwkeqlhpvci7fhzrl3jr5bjzq

1 reference